MIEN1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| migration and invasion enhancer 1 | MIM:611802 | Ensembl:ENSG00000141741 | HGNC:HGNC:28230 | PA134947080 | 17q12 |
GO terms in MIEN1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IEA | GO:0006915 | apoptotic process |
| BP | IBA | GO:0010269 | response to selenium ion |
| BP | IDA | GO:0030335 | positive regulation of cell migration |
| BP | IBA | GO:0043066 | negative regulation of apoptotic process |
| BP | IDA | GO:0043066 | negative regulation of apoptotic process |
| BP | IBA | GO:0051491 | positive regulation of filopodium assembly |
| BP | IDA | GO:0051491 | positive regulation of filopodium assembly |
| CC | IBA | GO:0005829 | cytosol |
| CC | IDA | GO:0005829 | cytosol |
| CC | IDA | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane |
| MF | IPI | GO:0005515 | protein binding |
Gene expression in normal tissue: MIEN1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MIEN1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD483 | SCH-529074 | 1 |
| iGMDRD68 | Paclitaxel | 1 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD434 | BMS-536924 | 5 |
| iGMDRD255 | SB225002 | 8 |
| iGMDRD137 | Indisulam | 1 |
| iGMDRD356 | PNU-74654 | 2 |
| iGMDRD886 | Compound 1541A | 1 |
| iGMDRD60 | Quinoclamine | 5 |
| iGMDRD506 | Fedratinib | 10 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD398 | Sepantronium | 2 |
| iGMDRD366 | PI-103 | 9 |
| iGMDRD100 | Zebularine | 4 |
| iGMDRD286 | Nsc 632839 | 8 |
| iGMDRD887 | Compound 23 citrate | 1 |
| iGMDRD74 | Idarubicin | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MIEN1
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.